lomerizine has been researched along with Migraine Disorders in 13 studies
lomerizine: used to treat migraines
Migraine Disorders: A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Lomerizine, a calcium channel blocker, may be effective as a treatment for migraine-associated vertigo (MAV)." | 9.12 | Migraine-associated vertigo: clinical characteristics of Japanese patients and effect of lomerizine, a calcium channel antagonist. ( Chihara, Y; Ito, K; Iwasaki, S; Murofushi, T; Sugasawa, K; Ushio, M, 2007) |
| "Lomerizine, a calcium channel blocker, may be effective as a treatment for migraine-associated vertigo (MAV)." | 5.12 | Migraine-associated vertigo: clinical characteristics of Japanese patients and effect of lomerizine, a calcium channel antagonist. ( Chihara, Y; Ito, K; Iwasaki, S; Murofushi, T; Sugasawa, K; Ushio, M, 2007) |
| "Thirty-three migraineurs (25 women and 8 men) participated in this study." | 1.46 | Treatment with telmisartan, a long-acting angiotensin II receptor blocker, prevents migraine attacks in Japanese non-responders to lomerizine. ( Ebina, J; Hanashiro, S; Hirayama, T; Ikeda, K; Ishikawa, Y; Iwasaki, Y; Kano, O; Kawabe, K; Kyuzen, M; Miura, K; Morioka, H; Nagasawa, J; Sawada, M; Takazawa, T; Yanagihashi, M, 2017) |
| "The study included patients with migraine who were admitted to outpatient clinics in Tokyo between January 2010 and July 2010 or between January 2011 and July 2011 and who were prescribed lomerizine prophylactically for headache by specialists." | 1.40 | Influence of the Tohoku-Pacific Ocean earthquake and its aftershocks on the response to prophylactic therapy with lomerizine in patients with migraine in Tokyo: a retrospective study. ( Ishii, M; Katoh, H; Kawamura, M; Shimizu, S; Takagi, M, 2014) |
| "Migraine is one of the risk factor for ischemic stroke." | 1.37 | Neuroprotection by lomerizine, a prophylactic drug for migraine, against hydrogen peroxide-induced hippocampal neurotoxicity. ( Iizuka, R; Ishii, M; Kiuchi, Y; Mori, Y; Shimizu, S, 2011) |
| "Therefore, goshuyuto may ameliorate migraine by preventing the hyper-aggregation of platelets in migraine with aura." | 1.35 | Goshuyuto, a traditional Japanese medicine for migraine, inhibits platelet aggregation in guinea-pig whole blood. ( Hibino, T; Kanno, H; Kase, Y; Takeda, A; Terawaki, K; Yuzurihara, M, 2008) |
| "Lomerizine was 3 to 1000 times more potent than flunarizine in the above SD models." | 1.30 | [Anti-migraine effects of lomerizine]. ( Hara, H; Hashimoto, M; Shimazawa, M; Sukamoto, T, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (23.08) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, MK | 1 |
| Wang, SJ | 1 |
| Ishii, M | 4 |
| Katoh, H | 2 |
| Kurihara, T | 1 |
| Kawamura, M | 2 |
| Shimizu, S | 4 |
| Takagi, M | 1 |
| Ikeda, K | 1 |
| Hanashiro, S | 1 |
| Ishikawa, Y | 1 |
| Sawada, M | 1 |
| Kyuzen, M | 1 |
| Morioka, H | 1 |
| Ebina, J | 1 |
| Nagasawa, J | 1 |
| Yanagihashi, M | 1 |
| Miura, K | 1 |
| Hirayama, T | 1 |
| Takazawa, T | 1 |
| Kano, O | 1 |
| Kawabe, K | 1 |
| Iwasaki, Y | 1 |
| Hibino, T | 1 |
| Yuzurihara, M | 1 |
| Terawaki, K | 1 |
| Kanno, H | 1 |
| Kase, Y | 1 |
| Takeda, A | 1 |
| Kobayashi, S | 1 |
| Ohkura, M | 1 |
| Yamamoto, R | 1 |
| Kiuchi, Y | 2 |
| Negoro, K | 1 |
| Iizuka, R | 1 |
| Mori, Y | 1 |
| Imai, N | 1 |
| Konishi, T | 1 |
| Serizawa, M | 1 |
| Okabe, T | 1 |
| Iwasaki, S | 1 |
| Ushio, M | 1 |
| Chihara, Y | 1 |
| Ito, K | 1 |
| Sugasawa, K | 1 |
| Murofushi, T | 1 |
| Hashimoto, M | 2 |
| Yamamoto, Y | 1 |
| Takagi, H | 2 |
| Takashima, M | 1 |
| Liou, SY | 1 |
| Hara, H | 1 |
| Shimazawa, M | 1 |
| Sukamoto, T | 1 |
1 review available for lomerizine and Migraine Disorders
| Article | Year |
|---|---|
[Calcium antagonists in the prophylactic treatment of migraine].
Topics: Calcium Channel Blockers; Calcium Channels; Drug Administration Schedule; Flunarizine; Humans; Hypox | 2009 |
2 trials available for lomerizine and Migraine Disorders
| Article | Year |
|---|---|
Do the effects of long-term lomerizine administration differ with age?
Topics: Adolescent; Adult; Age Factors; Calcium Channel Blockers; Drug Administration Schedule; Female; Huma | 2007 |
Migraine-associated vertigo: clinical characteristics of Japanese patients and effect of lomerizine, a calcium channel antagonist.
Topics: Adolescent; Adult; Asian People; Calcium Channel Blockers; Evoked Potentials; Female; Humans; Male; | 2007 |
10 other studies available for lomerizine and Migraine Disorders
| Article | Year |
|---|---|
Nomenclature for flunarizine, cinnarizine, and lomerizine.
Topics: Calcium Channel Blockers; Cinnarizine; Flunarizine; Humans; Migraine Disorders; Piperazines; Termino | 2020 |
Characteristics of inconsistent responders to prophylaxis therapy with lomerizine in patients with migraine: a retrospective study in Japan.
Topics: Adult; Calcium Channel Blockers; Female; Humans; Japan; Male; Middle Aged; Migraine Disorders; Multi | 2013 |
Influence of the Tohoku-Pacific Ocean earthquake and its aftershocks on the response to prophylactic therapy with lomerizine in patients with migraine in Tokyo: a retrospective study.
Topics: Adult; Calcium Channel Blockers; Earthquakes; Female; Humans; Japan; Male; Migraine Disorders; Pacif | 2014 |
Treatment with telmisartan, a long-acting angiotensin II receptor blocker, prevents migraine attacks in Japanese non-responders to lomerizine.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Calcium Channel Blockers; | 2017 |
Goshuyuto, a traditional Japanese medicine for migraine, inhibits platelet aggregation in guinea-pig whole blood.
Topics: Animals; Collagen; Drugs, Chinese Herbal; Guinea Pigs; Indicators and Reagents; Male; Migraine Disor | 2008 |
Inhibitory effect of lomerizine, a prophylactic drug for migraines, on serotonin-induced contraction of the basilar artery.
Topics: Animals; Basilar Artery; Calcium Channel Blockers; Male; Migraine Disorders; Piperazines; Rats; Rats | 2009 |
Neuroprotection by lomerizine, a prophylactic drug for migraine, against hydrogen peroxide-induced hippocampal neurotoxicity.
Topics: Animals; Benzamides; Calcium; Calcium Channel Blockers; Cell Death; Cells, Cultured; HEK293 Cells; H | 2011 |
Effects of KB-2796 on plasma extravasation following antidromic trigeminal stimulation in the rat.
Topics: Animals; Calcium Channel Blockers; Capillary Permeability; Capsaicin; Electric Stimulation; Glycopep | 1997 |
[Effect of KB-2796, a novel calcium channel blocker, on spreading depression in rat hippocampal slices].
Topics: Animals; Calcium Channel Blockers; Cortical Spreading Depression; Flunarizine; Hippocampus; Histamin | 1998 |
[Anti-migraine effects of lomerizine].
Topics: Animals; Calcium Channel Blockers; Cerebrovascular Circulation; Cortical Spreading Depression; Fluna | 1998 |